Dec 28, 2016 6:30 AM

VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference

Dec 01, 2016 8:57 AM

VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference

Nov 11, 2016 6:30 AM

VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016

Nov 10, 2016 6:30 AM

VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update

Nov 04, 2016 6:30 AM

VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update

Nov 03, 2016 6:30 AM

VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study

Oct 26, 2016 7:30 AM

VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition

Oct 21, 2016 12:34 PM

VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter

Oct 17, 2016 7:30 AM

Triage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee

Oct 11, 2016 9:30 AM

Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%

Oct 05, 2016 1:14 PM

VolitionRx Limited Announces Closing of Public Offering of Common Stock

Sep 30, 2016 9:45 AM

VolitionRx Limited Announces Pricing of Public Offering of Common Stock

Sep 29, 2016 5:02 PM

VolitionRx Limited Announces Proposed Public Offering of Common Stock

Sep 07, 2016 7:30 AM

VolitionRx to Attend Several Conferences in September

Sep 06, 2016 7:30 AM

Volition's Nu.Q Triage Colorectal Cancer Screening Test Expected to Reduce Colonoscopy Referral by 25 Percent

Sep 01, 2016 7:30 AM

VolitionRx Schedules Product Launch Update Conference Call for Tuesday, September 6, 2016 at 8:30 am ET

Aug 11, 2016 7:30 AM

VolitionRx Announces Second Quarter 2016 Financial Results and Business Update

Aug 08, 2016 7:30 AM

VolitionRx Schedules Second Quarter 2016 Earnings Conference Call and Business Update for Thursday, August 11, 2016 at 8:30am ET

Aug 02, 2016 8:00 AM

VolitionRx Engages Edison Advisors as Investor Relations Counsel

Jul 27, 2016 8:00 AM

VolitionRx Granted Fourth U.S. Patent

Jun 24, 2016 8:00 AM

VolitionRx Appoints Dr. Edward Futcher to Board of Directors

Jun 14, 2016 8:02 AM

VolitionRx Publishes Study Confirming Stability of Circulating Cell-Free Nucleosomes as Biomarkers for Cancer Diagnostic Blood Tests

May 31, 2016 10:16 AM

VolitionRx to Present at Two Upcoming Conferences in June

May 19, 2016 8:00 AM

VolitionRx to Present Data Demonstrating Accuracy of NuQ® Blood Test in Detecting Colorectal Cancer at World Endoscopy Organization (WEO) Meeting

May 13, 2016 8:00 AM

VolitionRx Announces First Quarter 2016 Financial Results and Business Update

May 12, 2016 8:00 AM

VolitionRx Initiates Clinical Trial with German Cancer Research Center (DKFZ) to Evaluate NuQ(R) Blood Test for Pancreatic Cancer

May 09, 2016 8:00 AM

VolitionRx Schedules First Quarter 2016 Earnings Conference Call and Business Update for Friday, May 13, 2016 at 8:30am ET

Apr 20, 2016 10:00 AM

VolitionRx Announces Study Results Showing NuQ® Blood Test Detects Prostate Cancer Early with Significantly Higher Accuracy than PSA Test

Apr 14, 2016 8:00 AM

VolitionRx Appoints Louise Day as Chief Marketing and Communications Officer

Apr 11, 2016 8:00 AM

VolitionRx to Participate in 2016 Morgan Stanley Healthcare Insight Series

Apr 08, 2016 8:00 AM

VolitionRx to Present at AACR Annual Meeting and Announce First Results from Prostate Cancer Study

Apr 07, 2016 8:08 AM

VolitionRx Announces CE Marks for Two NuQ® Blood Assays for Detection of Colorectal Cancer

Mar 23, 2016 11:30 AM

VolitionRx Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full

Mar 18, 2016 9:29 AM

VolitionRx Announces Pricing of Public Offering of Common Stock

Mar 17, 2016 4:01 PM

VolitionRx Announces Proposed Public Offering of Common Stock

Mar 11, 2016 7:35 AM

VolitionRx Announces Full Year 2015 Financial Results and Business Update

Mar 09, 2016 8:30 AM

VolitionRx Schedules Full-Year 2015 Earnings Conference Call and Business Update for Friday, March 11, 2016 at 8:30am ET

Mar 09, 2016 7:00 AM

Preliminary Data Demonstrates 86% Accuracy in Detecting Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease

Feb 17, 2016 7:00 AM

VolitionRx Demonstrates 75% Accuracy in Detecting Highest-Risk Pre-Cancerous Colorectal Adenomas with NuQ® Blood Test

Feb 04, 2016 7:00 AM

VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection